7 completed, 1 terminated. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 7, Terminated 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Diabetic Neuropathy: new trials by email Literature Review of Diabetic Neuropathy trials Research Report on Diabetic Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CGM-Guided Acarbose for Painful Diabetic Neuropathy Acarbose 50 mg, Placebo - Diabetes, Diabetes Complications | Phase 1 | Completed | Shifa International Hospital | 170 | 2025-09-01 | 2026-03-03 |
| Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy BOL-DP-o-04, Placebo - Diabetic Neuropathy | Phase 1 / Phase 2 | Terminated | Breath of Life International Pharma Ltd | 2 | 2019-04-15 | 2021-03-24 |
| Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga yoga - Diabetic Neuropathy | Phase 1 | Completed | Colorado State University | 15 | 2014-09-01 | 2016-01-20 |
| A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain 600㎍ of DA-3030 Injection, Placebo - Diabetic Neuropathy | Phase 1 | Completed | Dong-A Pharmaceutical Co., Ltd. | 31 | 2010-06-01 | 2013-08-13 |
| Neuropathic Pain Syndrome Patient Study (MK-0000-072) Comparator: pregabalin, Comparator: Placebo (unspecified) - Neuralgia, Postherpetic, Diabetic Neuropathy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 104 | 2007-12-01 | 2015-05-07 |
| Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain AV411 - Diabetic Neuropathy | Phase 1 / Phase 2 | Completed | Avigen | 36 | 2006-09-01 | 2007-12-19 |
| Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy hVEGF-A - Diabetic Neuropathy | Phase 1 | Completed | Sangamo Therapeutics | 12 | 2005-04-01 | 2011-06-08 |
| VEGF Gene Transfer for Diabetic Neuropathy VEGF - Diabetic Neuropathy | Phase 1 / Phase 2 | Completed | Losordo, Douglas, M.D. | 60 | 2002-12-01 | 2010-11-11 |
Diabetic Neuropathies (8) · Diabetes Mellitus (3) · Diabetes Complications (1) · Neuralgia, Postherpetic (1) · Pain (1) · Peripheral Arterial Disease (1)
Endocrine System Diseases (8) · Nervous System Diseases (8) · Neuromuscular Diseases (8) · Peripheral Nervous System Diseases (8) · Diabetes Complications (7) · Diabetes Mellitus (5) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1)
Acarbose (1) · Vascular Endothelial Growth Factor A (1) · Yoga (1) · ibudilast (1)
Avigen (1) · Breath of Life International Pharma Ltd (1) · Colorado State University (1) · Dong-A Pharmaceutical Co., Ltd. (1) · Losordo, Douglas, M.D. (1) · Merck Sharp & Dohme LLC (1) · Sangamo Therapeutics (1) · Shifa International Hospital (1)
United States (2) · Australia (1) · Israel (1) · Pakistan (1) · South Korea (1)
Allan H Ropper, M.D. (1) · Bong Yeon Cha, M.D., Ph.D. (1) · Choon Hee Chung, M.D., Ph.D. (1) · In Joo Kim, M.D., Ph.D. (1) · Kyung Soo Ko, M.D, Ph.D. (1) · Tae Sun Park, M.D., Ph.D. (1) · Yoo Heon Ahn, M.D., Ph.D. (1) · Young Soo Park, M.D.,Ph.D. (1)